• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Research Briefing on 4-CHLORO-6-HYDRAZINYL-5-METHOXYPYRIMIDINE (CAS: 1538678-39-5) in Chemical and Biomedical Applications

4-CHLORO-6-HYDRAZINYL-5-METHOXYPYRIMIDINE (CAS: 1538678-39-5) is a pyrimidine derivative that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug discovery. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting kinase inhibition and nucleic acid metabolism. Recent studies have highlighted its potential in the development of novel therapeutics for cancer, infectious diseases, and inflammatory disorders.

The structural features of 4-CHLORO-6-HYDRAZINYL-5-METHOXYPYRIMIDINE, including the hydrazinyl and chloro substituents, make it a valuable scaffold for further chemical modifications. Researchers have exploited these functional groups to design and synthesize analogs with enhanced pharmacological properties. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of this compound in the development of selective kinase inhibitors, showing promising results in preclinical models of breast cancer.

In addition to its role in drug discovery, 4-CHLORO-6-HYDRAZINYL-5-METHOXYPYRIMIDINE has been investigated for its potential in chemical biology. A recent report in ACS Chemical Biology detailed its use as a probe to study enzyme mechanisms, particularly those involving pyrimidine metabolism. The compound's ability to form stable complexes with certain enzymes has provided insights into their catalytic mechanisms and substrate specificity.

From a synthetic perspective, advances in the preparation of 4-CHLORO-6-HYDRAZINYL-5-METHOXYPYRIMIDINE have been reported, with researchers focusing on optimizing yield and purity. A 2024 publication in Organic Process Research & Development described a scalable and environmentally friendly synthesis route, which could facilitate its broader application in industrial settings. This development is particularly relevant given the increasing demand for high-quality intermediates in pharmaceutical manufacturing.

Looking ahead, the potential applications of 4-CHLORO-6-HYDRAZINYL-5-METHOXYPYRIMIDINE appear promising. Ongoing research is exploring its use in combination therapies and as part of targeted drug delivery systems. Furthermore, computational studies are being conducted to predict its interactions with various biological targets, which could accelerate the discovery of new therapeutic agents. As the understanding of its pharmacological profile deepens, this compound is likely to remain a focus of innovation in chemical and biomedical research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)